Loading stock data…
Evolent Health, Inc (EVH)
$4.22-0.42 (-9.05%)
Market ClosedLast close Jul 24
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Evolent Health, Inc. in the Healthcare sector is trading at $4.22 with a market capitalization of $425M. Wall Street consensus targets $6.06 (13 analysts), implying a +43.5% move over the next 12 months. The stock is currently 59% below its 52-week high of $10.29, remaining 0.7% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +43.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 28) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $496.25M↑ | $468.72M↓ | $479.53M↑ | $444.33M↓ | $483.65M |
| Gross Profit | $83.77M↓ | $97.25M↓ | $99.77M↓ | $100.39M↓ | $102.47M |
| Operating Income | -$10.60M↑ | -$20.44M↓ | -$1.43M↓ | $2.04M↑ | $4,000 |
| Net Income | -$26.63M↑ | -$429.13M↓ | -$20.86M↓ | -$19.90M↑ | -$64.62M |
Peer Comparison
JNJUNHPFE
Fundamentals
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administratio...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$425.18M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.83
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-125.26%
Volume
Today's trading volume
5.29M
Recent News
Why Evolent Health (EVH) Stock Is Nosediving
Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 13% in the afternoon session after Wall Street firm Citi downgraded the company's stock from Buy to Neutral. Despite raising the price target from $5.50 to $6.75, the investment firm reassessed the stock's potential, citing a less attractive risk-to-reward setup following a recent price increase. Analysts highlighted uncertainties surrounding healthcare exchange dis-enrollment and shifts in patient care needs. Additionally, Ci
Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI.
The “Mag Seven” has become the “Bag Seven.” Sharp tech investors are looking elsewhere.
3 Unprofitable Stocks with Questionable Fundamentals
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
American Well (AMWL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.